Recurrent Adult Immunoblastic Large Cell Lymphoma Active Not Recruiting Phase Trials for DB00099 (Filgrastim)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02037256Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell TransplantTreatment